|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02370 REDCO HEALTHY
Nominal 
1.260 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 194,013 | -7.173% | 400,535 | 419,635 | 449,273 | 437,113 |
| Cost of Sales | (155,088) | -1.067% | (303,628) | (306,206) | (323,601) | (294,239) |
| Gross Profit | 38,925 | -25.494% | 96,907 | 113,429 | 125,672 | 142,874 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (6,013) | (24,651) | -- | -- | |
| Change in FV & Impairment on Others | (2,916) | -81.612% | (21,508) | (40,981) | (63,389) | (69,151) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 339 | -- | 179 | 1,759 | 1,580 | 1,055 | |
| Profit / (Loss) before Taxation | 4,108 | 46.088% | (4,195) | (11,254) | 6,934 | 16,037 | |
| Taxation | (2,993) | -17.229% | (5,058) | (8,836) | (6,667) | (6,084) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,691) | -25.253% | (8,286) | (8,338) | (10,250) | (6,764) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (2,576) | -55.138% | (17,539) | (28,428) | (9,983) | 3,189 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 285 | -- | 139 | (234) | 615 | 1,036 |
| Depreciation & Amortisation | 4,700 | -12.182% | 11,980 | 13,393 | 15,579 | 11,725 |
| Directors' Emoluments | -- | -- | -- | 4,473 | 3,406 | 2,314 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified (Modified Report) |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -1.290 | -55.052% | -8.770 | -14.210 | -4.990 | 1.700 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.040 | (0.100) | 0.406 | (0.167) |
| NBV per share ($) | 1.215 | -- | 1.219 | 1.314 | 1.456 | 1.504 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -2,576 |
| %Change | -55.138% |
| EPS / (LPS) | RMB -0.013 |
| NBV Per Share (¥) | RMB 1.215 |